The Annual General Meeting (AGM) of SyntheticMR AB (publ) was held on May 20, 2025, whereby the meeting resolved in accordance with the Nomination Committee and Board's proposed resolutions. The full resolutions are stated in the notice of the meeting.

The following resolutions were made at the AGM:

The AGM resolved to approve the Board's proposal that no dividend will be paid. The remaining capitalized funds of SEK 71,928,452 including the share premium reserve and retained earnings, are transferred in new accounts.

The AGM resolved to grant the Board of directors and CEO discharge.

The AGM decided that the Board should consist of 5 ordinary members and no deputies. The AGM resolved on the re-election of Board members Johanna Fälting, Gisli Hennermark, Ann-Christine Sundell, Staffan Persson and Jan Bertus Marten (Marcel) Warntjes. Further, the AGM decided to elect Gisli Hennermark as the Chairman of the Board.

The AGM resolved that a Nomination Committee should be appointed by the Annual General Meeting instructing the Chairman of the Board to contact the three largest shareholders (hereby both direct registered shareholders and nominee-registered shareholders) in accordance with Euroclear Sweden AB's printout of the share register as of September 30, 2025.

The AGM resolved to authorize the board of directors until the next annual general meeting, on one or more occasions, with or without preferential rights for the shareholders, to issue shares, convertibles and/or warrants, with the right to subscribe for and convert into shares in the company, respectively, corresponding to a maximum of ten (10) percent of the company's share capital after dilution based on the number of shares in the company at the time when the authorization is used for the first time, to be paid in cash, through set-off or in kind.

For further information, please contact Johanna Norén, Acting CEO, CFO SyntheticMR AB, +46 70 619 21 00.

.